Assobiotec - English version

25 March 2024

Agreement between Bioindustry Park and Federated Innovation @Mind to accelerate the creation of a virtual district in life science

Working together to develop an innovative and competitive healthcare ecosystem, by focusing on digital and healthcare innovation trends, and strengthening the research and internationalisation of the production sector. This is the aim of the collaboration agreement signed by Federated Innovation @MIND and Bioindustry Park Silvano Fumero, reference points for companies in Lombardy and Piedmont operating in the public and private health and Life Sciences sectors.

08 January 2024

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide

290 patients participate at study centers in Europe, Asia and Latin America. Results from the study are expected in March 2024.

21 December 2023

Axxam and Lundbeck's Partnership for Lead Identification

The signature of this first partnership agreement between Axxam and Lundbeck, for the identification and qualification of small molecules relevant to CNS targets, comes after more than five years of successful collaboration in assay development and High-Throughput Screening.

16 November 2023

Momentum Biotechnologies and Axxam S.p.A. Announce Collaboration to Provide Unique Drug Discovery Solutions

Through the partnership Axxam’s highly curated chemical diversity library, comprised of 325,000 compounds, will be available for high-throughput screening using Momentum’s mass spectrometry-based func􀀛onal and binding assay platforms.

09 November 2023

Assobiotec signs an agreement with the European Biosolutions Coalition

Assobiotec has signed, in the framework of the Ecomondo Fair, an agreement with the European Biosolutions Coalition: an international reality born last 26 October in Brussels, with the aim of identifying and overcoming the European regulatory obstacles that slow down the spread of biotechnological solutions in the agricultural and industrial fields

02 November 2023

Highlights of the 5th edition of HTID®, organized by HealthTech For Care

Assobiotec was a partner of the HealthTech Innovation Days (HTID®) that brought together 750 participants on October 24 and 25, and remotely on October 27, including researchers, public players, industry leaders, patients’ associations, patients, investors and entrepreneurs in Paris.

Go to the

News

Agreement between Bioindustry Park and Federated Innovation @Mind to accelerate the creation of a virtual district in life science

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide

Axxam and Lundbeck's Partnership for Lead Identification

Momentum Biotechnologies and Axxam S.p.A. Announce Collaboration to Provide Unique Drug Discovery Solutions

Assobiotec signs an agreement with the European Biosolutions Coalition

Highlights of the 5th edition of HTID®, organized by HealthTech For Care

Partner

Where to find us